Anteris Technologies Global Corp. (ASX:AVR)
Australia · Delayed Price · Currency is AUD 8.07
+0.29 (3.73%)
Feb 11, 2026, 4:10 PM AEST
ASX:AVR Market Cap
ASX:AVR has a market cap or net worth of 756.47 million as of February 10, 2026. Its market cap has increased by 132.07% in one year.
Market Cap
756.47M
Enterprise Value
745.72M
Revenue
3.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.07
Market Cap Chart
Since June 27, 2011, ASX:AVR's market cap has increased from 985.19K to 756.47M, an increase of 76,683.86%. That is a compound annual growth rate of 57.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 756.47M | 137.67% |
| Dec 31, 2025 | 318.29M | 7.09% |
| Dec 31, 2024 | 297.22M | -12.90% |
| Dec 29, 2023 | 341.26M | 10.57% |
| Dec 30, 2022 | 308.62M | 114.65% |
| Dec 31, 2021 | 143.78M | 548.70% |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 1.97B |
| PolyNovo | 652.85M |
| Aroa Biosurgery | 241.83M |
| Lumos Diagnostics Holdings | 210.20M |
| EMVision Medical Devices | 167.75M |
| SomnoMed | 143.08M |
| Cleo Diagnostics | 85.54M |
| Compumedics | 74.91M |